Searching News Database: ENMD-2076
HSMN NewsFeed - 21 Sep 2015
CASI Pharmaceuticals to Raise $25.1 Million in Private Placement of Common Stock and Warrants
CASI Pharmaceuticals to Raise $25.1 Million in Private Placement of Common Stock and Warrants
HSMN NewsFeed - 4 Mar 2015
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer
HSMN NewsFeed - 25 Jul 2012
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
HSMN NewsFeed - 18 Jun 2008
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
HSMN NewsFeed - 3 Jan 2008
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
HSMN NewsFeed - 11 Dec 2007
EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
HSMN NewsFeed - 10 Sep 2007
EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!